MedTrace Logo

Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health

NCT06237959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-02-02

No results posted yet for this study

Summary

The purpose of this randomized, double-blind, placebo-controlled study will be to evaluate whether the daily intake of Keranat™ for 24 weeks can promote the gloss and elasticity of hairs, improve their density and strength, and reduce hair loss.

Conditions

  • Hair Damage

Interventions

DIETARY_SUPPLEMENT

Keranat™

300 mg/capsule(proso millet and wheat extract 600 mg/day)

DIETARY_SUPPLEMENT

placebo

300 mg/capsule(600 mg/day as placebo)

Sponsors & Collaborators

  • Novarex

    collaborator UNKNOWN

  • Nutracore

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-02
Primary Completion
2023-06-12
Completion
2023-12-11

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06237959 on ClinicalTrials.gov